Clinical Study

Impact of Intravenous Fluid Challenge Infusion Time on Macrocirculation and Endothelial Glycocalyx in Surgical and Critically Ill Patients

Table 4

Macrohemodynamic changes induced by fluid challenge in the whole population.

Variable Time-pointGroup FGroup SP value (between groups)
(N=32)(N=34)

MAP (mmHg)T077 ± 1178 ± 110.800
T185 ± 1378 ± 120.024
T6085 ± 1185 ± 120.986
p value0.0270.025

Pulse pressure (mmHg)T037 (30-43)35 (30-55)0.893
T140 (35-45)39 (30-51)0.338
T6038 (31-48)40 (31-61)0.496
p value0.2050.017

Heart rate (per minute)T069 (60-79)70 (63-81)0.603
T164 (59-75)68 (58-82)0.812
T6068 (63-87)74 (65-88)0.481
0.1740.209

Plethysmography Variability index (%) (OR cohort)T013 (7-20)15 (12-21)0.281
T110 (7-11)10 (7-14)0.276
T6013 (8-17)11 (10-15)0.879
p value0.0860.087

Stroke volume variation (%) (SEP cohort)T012 (10-19)5 (2-9)0.016
T16 (6-11)6 (4-10)0.568
T604 (4-14)7 (3-12)0.936
p value0.6210.013

Stroke volume index (ml/m2) (SEP cohort)T033 ± 1440 ± 200.515
T132 ± 1444 ± 200.320
T6033 ± 1344 ± 160.281
p value0.7500.563

Values are displayed as either median (interquartile range) or mean ± standard deviation; : significant difference towards baseline (RM ANOVA or Friedman test), significance marked in bold letters.
Abbreviations: Group F: fast administration; Group S: slow administration; MAP: mean arterial pressure; PVI: plethysmography variability index; SVV: stroke volume variation; PBR: perfused boundary region; SEP cohort: patients with sepsis/septic shock.